Supplemental table 1 from Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies

التفاصيل البيبلوغرافية
العنوان: Supplemental table 1 from Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies
المؤلفون: Yu Shen, Warren M. Kati, Keith F. McDaniel, Saul H. Rosenberg, Steven W. Elmore, Guowei Fang, Fred Kohlhapp, Xin Lu, Tamar Uziel, Lisa Hasvold, Dachun Liu, John K. Pratt, Steve Fidanze, Le Wang, George S. Sheppard, Cherrie K. Donawho, Denise Wilcox, Xiaoli Huang, Scott E. Warder, Emily J. Faivre, Lloyd T. Lam, Leiming Li, Daniel H. Albert, Xiaoyu Lin, Mai H. Bui
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Anti-proliferative activity of ABBV-075 across cancer cell lines
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2367dbc73927b229f960f4aa97c7304b
https://doi.org/10.1158/0008-5472.22414763.v1
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....2367dbc73927b229f960f4aa97c7304b
قاعدة البيانات: OpenAIRE